Beta Drugs Limited (NSE:BETA)
1,838.50
-32.50 (-1.74%)
At close: Nov 12, 2026
| Market Cap | 18.64B +10.3% |
| Revenue (ttm) | 4.10B +10.1% |
| Net Income | 455.86M +8.8% |
| EPS | 44.31 +6.8% |
| Shares Out | 10.14M |
| PE Ratio | 41.49 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,840 |
| Open | 1,891.40 |
| Previous Close | 1,871.00 |
| Day's Range | 1,806.10 - 1,891.80 |
| 52-Week Range | 990.10 - 2,807.90 |
| Beta | -0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |